UBS AM
ACHC icon

UBS AM’s Acadia Healthcare ACHC Stock Holding History

UBS AM’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.44M Sell
275,313
-4,556
-2% -$82.5K ﹤0.01% 1435
2025
Q4 		$3.97M Buy
279,869
+6,452
+2% +$122K ﹤0.01% 1581
2025
Q3 		$6.77M Sell
273,417
-144,765
-35% -$3.23M ﹤0.01% 1226
2025
Q2 		$9.49M Buy
418,182
+77,266
+23% +$1.83M ﹤0.01% 1378
2025
Q1 		$10.3M Buy
340,916
+27,207
+9% +$1.04M ﹤0.01% 1210
2024
Q4 		$12.4M Buy
313,709
+56,647
+22% +$2.56M ﹤0.01% 1144
2024
Q3 		$16.3M Sell
257,062
-6,112
-2% -$441K ﹤0.01% 1025
2024
Q2 		$17.8M Buy
263,174
+108,672
+70% +$7.59M 0.01% 903
2024
Q1 		$12.2M Buy
154,502
+16,828
+12% +$1.38M ﹤0.01% 932
2023
Q4 		$10.7M Sell
137,674
-6,590
-5% -$488K ﹤0.01% 958
2023
Q3 		$10.1M Buy
144,264
+3,179
+2% +$238K ﹤0.01% 948
2023
Q2 		$10.2M Hold
141,085
– – ﹤0.01% 967
2023
Q1 		$10.2M Sell
141,085
-11,944
-8% -$931K ﹤0.01% 967
2022
Q4 		$12.6M Buy
153,029
+5,994
+4% +$494K 0.01% 857
2022
Q3 		$11.5M Sell
147,035
-21,345
-13% -$1.71M 0.01% 913
2022
Q2 		$11.4M Buy
168,380
+16,489
+11% +$1.15M 0.01% 912
2022
Q1 		$9.95M Buy
151,891
+10,572
+7% +$614K ﹤0.01% 1068
2021
Q4 		$8.58M Sell
141,319
-10,011
-7% -$597K ﹤0.01% 1184
2021
Q3 		$9.65M Buy
151,330
+21,744
+17% +$1.37M ﹤0.01% 1109
2021
Q2 		$8.13M Buy
129,586
+10,157
+9% +$637K ﹤0.01% 1191
2021
Q1 		$6.82M Sell
119,429
-14,178
-11% -$767K ﹤0.01% 1215
2020
Q4 		$6.72M Buy
133,607
+22,981
+21% +$916K ﹤0.01% 1179
2020
Q3 		$3.26M Buy
110,626
+665
+0.6% +$19.3K ﹤0.01% 1332
2020
Q2 		$2.76M Sell
109,961
-18,380
-14% -$459K ﹤0.01% 1395
2020
Q1 		$2.36M Buy
128,341
+21,592
+20% +$618K ﹤0.01% 1343
2019
Q4 		$3.55M Buy
106,749
+5,836
+6% +$183K ﹤0.01% 1335
2019
Q3 		$3.14M Sell
100,913
-2,712
-3% -$82.6K ﹤0.01% 1408
2019
Q2 		$3.62M Buy
103,625
+572
+0.6% +$18.5K ﹤0.01% 1329
2019
Q1 		$3.02M Buy
103,053
+19,135
+23% +$542K ﹤0.01% 1341
2018
Q4 		$2.16M Buy
83,918
+1,253
+2% +$43.4K ﹤0.01% 1406
2018
Q3 		$2.91M Buy
82,665
+579
+0.7% +$23.1K ﹤0.01% 1346
2018
Q2 		$3.36M Buy
82,086
+8,074
+11% +$326K ﹤0.01% 1294
2018
Q1 		$2.9M Buy
74,012
+9,735
+15% +$357K ﹤0.01% 1319
2017
Q4 		$2.1M Sell
64,277
-246,188
-79% -$8.53M ﹤0.01% 1418
2017
Q3 		$14.8M Sell
310,465
-4,820
-2% -$235K 0.01% 809
2017
Q2 		$15.6M Sell
315,285
-17,070
-5% -$756K 0.02% 799
2017
Q1 		$14.5M Buy
332,355
+59,001
+22% +$2.39M 0.01% 808
2016
Q4 		$9.05M Sell
273,354
-19,044
-7% -$739K 0.01% 885
2016
Q3 		$14.5M Sell
292,398
-7,857
-3% -$409K 0.02% 787
2016
Q2 		$16.6M Buy
300,255
+91,675
+44% +$5.36M 0.02% 748
2016
Q1 		$11.5M Sell
208,580
-4,962
-2% -$283K 0.01% 810
2015
Q4 		$13.3M Sell
213,542
-3,337
-2% -$217K 0.02% 790
2015
Q3 		$14.4M Buy
216,879
+27,580
+15% +$2.12M 0.02% 775
2015
Q2 		$14.8M Buy
189,299
+12,519
+7% +$901K 0.01% 792
2015
Q1 		$12.7M Sell
176,780
-3,115
-2% -$200K 0.01% 819
2014
Q4 		$11M Buy
179,895
+1,315
+0.7% +$76.5K 0.01% 840
2014
Q3 		$8.66M Buy
178,580
+163,281
+1,067% +$7.98M 0.01% 882
2014
Q2 		$696K Buy
15,299
+700
+5% +$30.8K ﹤0.01% 1729
2014
Q1 		$659K Hold
14,599
– – ﹤0.01% 1725
2013
Q4 		$691K Buy
14,599
+3,000
+26% +$130K ﹤0.01% 1653
2013
Q3 		$457K Hold
11,599
– – ﹤0.01% 1833
2013
Q2 		$384K Buy
+11,599
New +$376K ﹤0.01% 1833

Other funds holding ACHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

UBS AM's ACHC Position: Q1 2026 in Review

UBS AM reduced its Acadia Healthcare (ACHC) stake by 1.6% in Q1 2026, selling an estimated $82.5K and leaving 275,313 shares worth $6.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1435.

UBS AM first reported a position in ACHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.8M in Q2 2024. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • UBS AM held 275,313 shares of Acadia Healthcare worth $6.44M as of Q1 2026.
  • UBS AM sold 4,556 Acadia Healthcare shares in Q1 2026, an estimated $82.5K.
  • Acadia Healthcare made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #1435 holding.
  • UBS AM first reported a position in Acadia Healthcare in Q2 2013 and has held it in 52 quarters since.
  • UBS AM's Acadia Healthcare position peaked at $17.8M in Q2 2024.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.